Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial (2022)
- Authors:
- Autor USP: CASTRO JUNIOR, GILBERTO DE - FM
- Unidade: FM
- DOI: 10.1007/s00520-021-06625-8
- Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO; MIOSITE; ESTUDOS RANDOMIZADOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Supportive care in cancer
- ISSN: 0941-4355
- Volume/Número/Paginação/Ano: v. 30, n. 3, p. 2225-2236, 2022
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
KAUARK-FONTES, Elisa et al. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial. Supportive care in cancer, v. 30, n. 3, p. 2225-2236, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00520-021-06625-8. Acesso em: 04 out. 2024. -
APA
Kauark-Fontes, E., Migliorati, C. A., Epstein, J. B., Treister, N. S., Alves, C. G. B., Faria, K. M., et al. (2022). Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial. Supportive care in cancer, 30( 3), 2225-2236. doi:10.1007/s00520-021-06625-8 -
NLM
Kauark-Fontes E, Migliorati CA, Epstein JB, Treister NS, Alves CGB, Faria KM, Palmier NR, Rodrigues-Oliveira L, Paglioni M de P, Castro Junior G de C. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial [Internet]. Supportive care in cancer. 2022 ; 30( 3): 2225-2236.[citado 2024 out. 04 ] Available from: https://doi.org/10.1007/s00520-021-06625-8 -
Vancouver
Kauark-Fontes E, Migliorati CA, Epstein JB, Treister NS, Alves CGB, Faria KM, Palmier NR, Rodrigues-Oliveira L, Paglioni M de P, Castro Junior G de C. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial [Internet]. Supportive care in cancer. 2022 ; 30( 3): 2225-2236.[citado 2024 out. 04 ] Available from: https://doi.org/10.1007/s00520-021-06625-8 - Diagnóstico de mutações ativadoras do gene EGFR em adenocarcinomas pulmonares: caracterização e implicações clínicas
- Efficacy and safety of ceritinib (450 mg/d or 600 mg/d) with food versus 750-mg/d fasted in patients with ALK receptor tyrosine kinase (ALK)-Positive NSCLC: primary efficacy results from the ASCEND-8 study
- Manual de oncologia torácica
- Lung Cancer in Brazil [Editorial]
- Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
- Noções de oncologia torácica
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- Pembrolizumab alone or with chemotherapy for recurrent/metastatic had and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by programmed death Ligand-1 combined positive score
- Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)
Informações sobre o DOI: 10.1007/s00520-021-06625-8 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
